QRxPharma Ltd (OTCQX International:QRXPY.PK)

Data as of Jan 27
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

QRxPharma Ltd. is a commercial-stage specialty pharmaceutical company. It is focused on the development and commercialization of new treatments for pain management and central nervous system disorders. The company's product portfolio includes MoxDuo IR, MoxDuo IV and MoxDuo CR. QRxPharma was founded by Pace W. Gary and Felix de la Iglesia on Setember 19, 2002 and is headquartered in Sydney, Australia.

Contact Information

QRxPharma Ltd.
194 Miller Street
Sydney New South Wales (nsw) 2060
P:(129) 492-8021
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Edward M. RudnicChief Executive Officer
Chris J. CampbellChief Financial Officer & Secretary
Patricia T. RichardsChief Medical Officer
M. Janette DixonSenior Vice President-Global Business Development
Michael SchroederVice President-Regulatory Affairs

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.